INmune Bio Inc [NASDAQ: INMB] slipped around 439382.63 points on Thursday, while shares priced at $439390.0 at the close of the session, down -14.79%.
INmune Bio Inc stock is now -16.60% down from its year-to-date (YTD) trading value. INMB Stock saw the intraday high of $7.6441 and lowest of $6.2 per share. The company’s 52-week high price is 10.50, which means current price is +32.77% above from all time high which was touched on 02/05/25.
Compared to the average trading volume of 439.39K shares, INMB reached a trading volume of 3193652 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about INmune Bio Inc [INMB]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for INMB shares is $23.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on INMB stock is a recommendation set at 1.17. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Rodman & Renshaw have made an estimate for INmune Bio Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 28, 2025. While these analysts kept the previous recommendation, Alliance Global Partners raised their target price to Buy. The new note on the price target was released on October 21, 2024, representing the official price target for INmune Bio Inc stock. Previously, the target price had yet another raise to $18, while Raymond James analysts kept a Outperform rating on INMB stock.
The Price to Book ratio for the last quarter was 4.85, with the Price to Cash per share for the same quarter was set at 0.83.
How has INMB stock performed recently?
INmune Bio Inc [INMB] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.26. With this latest performance, INMB shares dropped by -17.91% in over the last four-week period, additionally plugging by 42.73% over the last 6 months – not to mention a rise of 34.48% in the past year of trading.
INmune Bio Inc [INMB]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and INmune Bio Inc [INMB] shares currently have an operating margin of -83046.00%. INmune Bio Inc’s Net Margin is presently recorded at -81592.00%.
Return on Equity for this stock declined to -96.41%, with Return on Assets sitting at -96.41%.
Earnings analysis for INmune Bio Inc [INMB]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for INMB. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for INmune Bio Inc go to 14.10%.
Insider trade positions for INmune Bio Inc [INMB]
There are presently around $25.66%, or 35.74% of INMB stock, in the hands of institutional investors. The top three institutional holders of INMB stocks are: BLACKROCK INC. with ownership of 0.81 million shares, which is approximately 4.2103%. VANGUARD GROUP INC, holding 0.63 million shares of the stock with an approximate value of $$5.54 million in INMB stocks shares; and VANGUARD GROUP INC, currently with $$5.26 million in INMB stock with ownership which is approximately 3.0888%.
